Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability

<p>Abstract</p> <p>Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesot...

Full description

Bibliographic Details
Main Authors: Sacchi Ada, Altucci Lucia, Menegozzo Simona, Galati Rossella, Nebbioso Angela, Cardillo Irene, Verdina Alessandra, Baldi Alfonso
Format: Article
Language:English
Published: BMC 2008-05-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/6/1/27
_version_ 1818021713941626880
author Sacchi Ada
Altucci Lucia
Menegozzo Simona
Galati Rossella
Nebbioso Angela
Cardillo Irene
Verdina Alessandra
Baldi Alfonso
author_facet Sacchi Ada
Altucci Lucia
Menegozzo Simona
Galati Rossella
Nebbioso Angela
Cardillo Irene
Verdina Alessandra
Baldi Alfonso
author_sort Sacchi Ada
collection DOAJ
description <p>Abstract</p> <p>Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21<sup>waf1</sup>. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.</p>
first_indexed 2024-04-14T08:21:31Z
format Article
id doaj.art-f2e1bb2152464b69919c95d3d996b97a
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-14T08:21:31Z
publishDate 2008-05-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-f2e1bb2152464b69919c95d3d996b97a2022-12-22T02:04:11ZengBMCJournal of Translational Medicine1479-58762008-05-01612710.1186/1479-5876-6-27Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viabilitySacchi AdaAltucci LuciaMenegozzo SimonaGalati RossellaNebbioso AngelaCardillo IreneVerdina AlessandraBaldi Alfonso<p>Abstract</p> <p>Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21<sup>waf1</sup>. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.</p>http://www.translational-medicine.com/content/6/1/27
spellingShingle Sacchi Ada
Altucci Lucia
Menegozzo Simona
Galati Rossella
Nebbioso Angela
Cardillo Irene
Verdina Alessandra
Baldi Alfonso
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Journal of Translational Medicine
title Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
title_full Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
title_fullStr Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
title_full_unstemmed Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
title_short Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
title_sort molecular analysis of the effects of piroxicam and cisplatin on mesothelioma cells growth and viability
url http://www.translational-medicine.com/content/6/1/27
work_keys_str_mv AT sacchiada molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT altuccilucia molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT menegozzosimona molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT galatirossella molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT nebbiosoangela molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT cardilloirene molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT verdinaalessandra molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability
AT baldialfonso molecularanalysisoftheeffectsofpiroxicamandcisplatinonmesotheliomacellsgrowthandviability